Synthesis of 7‐Sulfamoyl‐substituted 2‐Oxo‐2,3,4,5‐tetrahydro‐1H‐benzo[b]azepines

References

• Tabrizchi , R. 2003 . SLV‐306 . Solvay. Curr. Opin. Investig. Drugs , 4 : 329 – 332 .
   Google Scholar
• Robl , J. A. , Simpkins , L. M. , Stevenson , J. , Sun , C. Q. , Murugesan , N. , Barrish , J. C. , Asaad , M. M. , Bird , J. E. , Schaeffer , T. R. , Trippodo , N. R. , Petrillo , E. W. and Karanewsky , D. S. 1994 . Dual metalloprotease inhibitors, I: Constrained peptodomimetics of mercaptoacyl dipeptides . Bioorg. Med. Chem. Lett. , 4 : 1789 – 1794 .
   Google Scholar
• Floyd , D. M. , Kimball , S. D. , Krapcho , J. , Das , J. , Turk , C. F. , Moquin , R. V. , Lago , M. W. , Duff , K. J. , Lee , V. G. and White , R. E. 1992 . Benzazepinone calcium channel blockers, 2: Structure–activity and drug metabolism studies leading to potent antihypertensive agents: Comparison with benzothiazepinones . J. Med. Chem. , 35 : 756 – 772 .
   PubMed Web of Science ®Google Scholar
• Donati , D. and Fabio , R. D. 2000 . Embolizing mobile thrombus associated with prolapse and mixoid degeneration of the mitral valve . Pharm. Acta Helv. , 74 : 239 – 246 .
   Google Scholar
• Kling , A. , Backfisch , G. , Delzer , J. , Geneste , H. , Graef , C. , Hornberger , W. , Lange , U. E. W. , Lauterbach , A. , Seitz , W. and Subkowski , T. 2003 . Bioorganic design and synthesis of 1,5‐ and 2,5‐substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists . Med. Chem. , 11 : 1319 – 1341 .
   Google Scholar
• Schoen , W. R. , Pisano , J. M. , Prendergast , K. , Wyvratt , M. J. Jr. , Fisher , M. H. , Cheng , K. , Chan , W. W. , Butler , B. , Smith , R. G. and Ball , R. G. 1994 . A novel 3‐substituted benzazepinone growth hormone secretagogue (L‐692,429) . J. Med. Chem. , 37 : 897 – 906 .
   PubMedGoogle Scholar
• http://www.mdl.com/products/knowledge/crossfire_beilstein/index.jsp
   Google Scholar
• Evans , B. E. , Rittle , K. E. , Bock , M. G. , DiPardo , R. M. , Freidinger , R. M. , Whitter , W. L. , Lundell , G. F. , Veber , D. F. , Anderson , P. S. , Chang , R. S. , Lotti , V. J. , Cerino , D. J. , Chen , T. B. , Kling , P. J. , Kunkel , K. A. , Springer , J. P. and Hirshfield , J. 1988 . Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists . J. Med. Chem. , 31 : 2235 – 2246 .
   PubMed Web of Science ®Google Scholar
• Horton , D. A. , Bourne , G. T. and Smythe , M. L. 2003 . The combinatorial synthesis of bicyclic privileged structures or privileged substructures . Chem. Rev. , 103 : 893 – 930 .
   PubMed Web of Science ®Google Scholar
• Mason , J. , Morize , I. , Menard , P. , Cheney , D. , Hulme , C. and Labaudiniere , R. 1999 . New 4‐point pharmacophore method for molecular similarity and diversity applications: Overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures . J. Med. Chem. , 42 : 3251 – 3264 .
   PubMed Web of Science ®Google Scholar
• Ito , Y. , Kobayashi , K. , Maeno , M. and Saegusa , T. 1980 . A new synthetic method for preparation of 1,3,4,5‐tetrahydro‐2H‐1‐benzazepin‐2‐one derivatives . Chem. Lett. , 5 : 487 – 490 .
   Google Scholar
• Chen , W.‐Y. and ;Gilman , N. W. 1983 . Synthesis of 7‐phenylpyrimido[5,4‐d][1]benzazepin‐2‐ones . J. Heterocycl. Chem. , 20 : 663 – 666 .
   Web of Science ®Google Scholar
• Asaad , M. M. , Robl , J. A. and Simpkins , L. M. 2000 . N‐Formylhydroxylaminecontainingdipeptides:Generationofanewclassofvasopeptidaseinhibitors . Bioorg. Med. Chem. Lett , 10 : 257 – 260 .
   Google Scholar
• Tamura , S. Y. , Goldman , E. A. , Semple , J. E. and Bergum , P. W. 1999 . Novel benzo‐fused lactam scaffolds as factor Xa inhibitors . Bioorg. Med. Chem. Lett. , 9 : 2573 – 2578 .
   Google Scholar